TFRC Native

Transferrin Receptor Human
Shipped with Ice Packs
In Stock

Description

Human Transferrin Receptor Protein produced in human serum tissue having a molecular mass of 85kDa.

Product Specs

Introduction
Transferrin receptor protein 1 (TFRC) is essential for cellular iron uptake from transferrin. Structurally, TFRC is a transmembrane glycoprotein formed by two disulfide-linked monomers, themselves connected by two disulfide bonds. Each monomer can bind one holo-transferrin molecule, creating an iron-Tf-TfR complex that enters the cell via endocytosis.
Description
Human Transferrin Receptor Protein, with a molecular weight of 85kDa, produced from human serum tissue.
Physical Appearance
Sterile Filtered brown solution.
Formulation
TFRC Native solution (0.2µm filtered) containing 250mM TRIS-HCl buffer, 0.15M NaCl, 0.09% NaN3, at a pH of 8.0.
Stability
For optimal storage, refrigerate at 4°C if the entire vial will be used within 2-4 weeks. For longer-term storage, freeze at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for extended storage. Avoid repeated freeze-thaw cycles.
Human Virus Test
The starting material donor has tested negative for antibodies to HIV-1, HIV-2, HCV, HBSAG, Parvovirus B19, Syphilis and HIV/HBV/HCV (PCR).
Synonyms

Transferrin receptor protein 1, TR, TfR, TfR1, Trfr, T9, p90, CD_antigen: CD71, Transferrin receptor, serum form, sTfR, TFRC, CD71

Source

Human serum.

Q&A

What is TFRC and what is its primary function in cellular biology?

TFRC (Transferrin Receptor 1 or TFR1) is a crucial type II transmembrane protein that regulates intracellular iron transport across cell membranes. It functions as a key mediator facilitating iron ion entry into cellular channels and plays a critical role in regulating cellular iron metabolism and maintaining iron homeostasis .

The protein comprises two homodimeric subunits linked by disulfide bonds, with each monomer consisting of a short N-terminal region, a single transmembrane segment, and a large extracellular domain that binds to iron-loaded transferrin. This binding initiates receptor-mediated endocytosis, allowing iron to enter cells through a controlled pathway.

How does native TFRC expression vary across different tissue types?

Native TFRC is expressed across various cell and tissue types in the human body, though expression levels vary significantly based on tissue-specific iron requirements. Tissues with high proliferation rates or specialized iron needs (such as erythroid precursors, placental tissue, and rapidly dividing cancer cells) demonstrate notably elevated TFRC expression compared to tissues with lower iron demands.

Tissue TypeRelative TFRC ExpressionFunctional Significance
Erythroid precursorsVery highEssential for hemoglobin synthesis
PlacentaHighMaternal-fetal iron transport
LiverModerateIron storage and regulation
BrainModerate to highNeurodevelopment and function
Cancer cellsVery high (often upregulated)Supports rapid proliferation
Skeletal muscleLowLimited iron turnover requirements

What experimental models are most appropriate for studying native TFRC function?

When designing experiments to study native TFRC function, researchers should select models that maintain physiological expression and regulation patterns while allowing for appropriate experimental manipulation.

For cellular studies, the choice of experimental model should reflect the research question:

  • Human cell lines expressing endogenous TFRC at physiological levels

  • Primary cells isolated from relevant tissues

  • Organoid models for three-dimensional tissue architecture

  • Animal models for in vivo physiological context

Experimental design should follow principles of randomization and appropriate controls. As noted in statistical design literature, "control what you can, block what you cannot, and randomize the rest" . This approach helps minimize bias and confounding variables in TFRC research.

How should researchers design experiments to study TFRC-mediated iron uptake?

When designing experiments to study TFRC-mediated iron uptake, researchers should consider:

  • Experimental Design Structure:

    • Implement a completely randomized design (CRD) or randomized block design (RBD) depending on whether potential confounding variables need to be controlled

    • Include appropriate positive and negative controls

    • Consider factorial designs when testing multiple factors affecting TFRC function

  • Sample Size Calculation:

    • Perform a priori power analysis based on expected effect size

    • For typical cell-based assays, plan for at least 3-5 biological replicates

    • For animal experiments, calculations should account for expected variability and ethical considerations for reduction

  • Key Methodological Approaches:

    • Fluorescently-labeled transferrin uptake assays

    • Radioactive iron (59Fe) incorporation studies

    • Live-cell imaging of TFRC trafficking

    • Quantitative analysis of iron-responsive element (IRE) regulation

Sample preparation and experimental timing should be carefully controlled and randomized within blocks to prevent systematic bias that could affect the interpretation of TFRC function.

What methodological challenges exist in studying native TFRC interactions with other proteins?

Studying native TFRC interactions presents several methodological challenges that researchers must address through careful experimental design:

  • Preserving Native Conformation:

    • Mild extraction conditions to maintain protein-protein interactions

    • Validation of antibody specificity for native TFRC epitopes

    • Use of crosslinking approaches to capture transient interactions

  • Distinguishing Direct vs. Indirect Interactions:

    • Implementation of proximity labeling techniques (BioID, APEX)

    • Confirmation with multiple methodologies (co-IP, FRET, PLA)

    • Careful design of negative controls to identify non-specific binding

  • Quantitative Analysis:

    • Application of appropriate statistical models for interaction data

    • Use of randomized block designs to control for batch effects

    • Implementation of mixed-effects models for nested experimental designs

Researchers should be particularly attentive to experimental design when studying the recently discovered TransTAC (transferrin receptor-targeted chimera) system, which leverages TFR1's endocytosis to drive co-internalization of target proteins and direct them toward lysosomal degradation .

How do experimental conditions affect native TFRC stability and function?

Experimental conditions significantly impact TFRC stability and function, necessitating careful control and documentation:

Experimental FactorImpact on TFRCMethodological Consideration
pHAffects transferrin binding affinity and iron releaseMaintain physiological pH (7.4) for binding studies; use pH 5.5 for endosomal studies
TemperatureInfluences endocytosis rate and protein foldingControl temperature precisely; avoid freeze-thaw cycles with native protein
Cell confluenceAffects expression levels and trafficking dynamicsStandardize cell density across experiments
Serum factorsPresence of transferrin in serum affects baseline activityConsider serum-free conditions with defined transferrin levels
Buffer compositionIonic strength affects binding kineticsUse physiologically relevant buffers; document composition fully

When designing experiments involving multiple conditions, researchers should implement randomized block designs to control for potential confounding variables . This is particularly important when studying TFRC in disease models where multiple factors may influence protein behavior simultaneously.

What statistical approaches are most appropriate for analyzing TFRC expression data across different experimental contexts?

When analyzing TFRC expression and functional data, researchers should select appropriate statistical approaches based on their experimental design:

  • For Comparing Multiple Treatment Groups:

    • ANOVA with appropriate post-hoc tests for multiple comparisons

    • Consider blocking factors to increase statistical power

    • For nested designs (e.g., multiple samples from the same source), use hierarchical or nested statistical models

  • For Time-Course Studies:

    • Repeated measures ANOVA or mixed-effects models

    • Account for potential correlation between time points

    • Consider time as both a fixed and random effect depending on study design

  • For Complex Multifactorial Experiments:

    • Factorial ANOVA designs to assess interaction effects

    • Response surface methods for optimization experiments

    • Sample size calculations should account for interaction terms and maintain adequate power

How should researchers approach studying the relationship between TFRC and cancer?

The relationship between TFRC and cancer represents a significant research area, as cancer cells require large amounts of iron for rapid proliferation, leading to significant upregulation of cell surface TFRC . Research approaches should include:

  • Experimental Design Considerations:

    • Include multiple cancer cell lines and matched normal controls

    • Use patient-derived samples to capture heterogeneity

    • Design factorial experiments to test interactions between TFRC expression and other variables (hypoxia, drug treatments)

    • Implement hierarchical statistical models to account for nested data structures

  • Methodological Approaches:

    • Comparative expression analysis across cancer types

    • Functional studies of iron dependency in cancer cells

    • Investigation of TFRC as a potential therapeutic target

    • Exploration of TransTAC technology for targeting cancer cells

  • Translational Research Framework:

    • Correlation of TFRC expression with clinical outcomes

    • Assessment of TFRC as a biomarker for treatment response

    • Development of TFRC-targeted therapeutic strategies

Recent work has demonstrated that TransTAC technology, which drives coendocytosis of target proteins with TFR1 from the cell surface and into lysosomal degradation pathways, represents a promising new class of bifunctional antibody family for cancer therapies .

What are the recommended protocols for studying TFRC in mixed cell populations or complex tissue samples?

Studying TFRC in heterogeneous samples requires specialized approaches to differentiate cell-specific expression and function:

  • Sample Processing and Analysis:

    • Single-cell approaches to resolve cellular heterogeneity

    • Laser capture microdissection for isolating specific cell populations

    • Flow cytometry with multiple markers to identify TFRC-expressing subpopulations

    • Spatial transcriptomics or proteomics to preserve tissue architecture information

  • Statistical and Experimental Design Considerations:

    • Increased sample sizes to account for heterogeneity

    • Nested or hierarchical experimental designs

    • Mixed effects models to account for both fixed and random factors

    • Loop designs for comparing multiple tissue types with limited samples

  • Validation Across Methods:

    • Triangulation of results using complementary approaches

    • Quantitative image analysis with spatial statistics

    • Integration of -omics data with functional assays

For researchers working with diverse populations, including indigenous or mixed-ancestry communities, additional ethical considerations are essential. These should include appropriate community engagement, recognition of sovereignty, and development of research relationships based on "truth, respect, justice and shared humanity" .

How can researchers optimize experimental designs for studying TFRC regulation mechanisms?

Optimizing experimental designs for TFRC regulation requires careful consideration of multiple factors:

  • Design Selection and Planning:

    • Choose between completely randomized designs (CRD), randomized block designs (RBD), or factorial designs based on research questions

    • Consider the use of covariates to increase statistical power

    • Plan for potential loss of samples by including additional experimental units

  • Sample Size Determination:

    • Calculate required sample sizes based on:

      • Expected effect size (from preliminary data)

      • Desired statistical power (typically 80% or higher)

      • Significance level (usually α = 0.05)

      • Variability within and between experimental units

  • Randomization and Blinding:

    • Implement computer-generated randomization schedules

    • Use blinded analysis where possible to prevent bias

    • Document randomization methods in protocols and publications

  • Control Implementation:

    • Include positive and negative controls for all critical assays

    • Consider the use of internal standards for quantitative measurements

    • Implement appropriate vehicle controls for any treatments

As noted in statistical design literature, "a statistical mantra we should keep in mind is control what you can, block what you cannot, and randomize the rest" . This principle is particularly important when studying complex regulatory mechanisms like those controlling TFRC expression.

What are the current technological advances in studying native TFRC structure and dynamics?

Recent technological advances have significantly enhanced our ability to study native TFRC:

  • Structural Biology Approaches:

    • Cryo-electron microscopy for near-atomic resolution structures

    • Hydrogen-deuterium exchange mass spectrometry for conformational dynamics

    • Single-molecule FRET for studying dynamic structural changes

    • In-cell NMR for examining TFRC in its native cellular environment

  • Live Cell Imaging Technologies:

    • Super-resolution microscopy for tracking TFRC trafficking

    • CRISPR-based tagging of endogenous TFRC

    • Correlative light and electron microscopy (CLEM) for structural context

    • Quantitative FRAP analysis for membrane dynamics

  • Computational Methods:

    • Molecular dynamics simulations of TFRC-transferrin interactions

    • AI-assisted analysis of trafficking patterns

    • Systems biology modeling of iron regulation networks

These technologies provide unprecedented insights into TFRC function but require careful experimental design and statistical analysis to yield reliable results. Researchers should consider factorial designs when testing multiple variables affecting TFRC structure or function, and implement appropriate randomization within experimental blocks .

How should researchers approach translational studies linking TFRC to disease mechanisms?

Translational studies on TFRC require rigorous experimental designs that bridge basic research findings with clinical applications:

  • Experimental Design Frameworks:

    • Implement case-control designs with appropriate matching

    • Consider adaptive sample size approaches for clinical studies

    • Use factorial designs to assess interactions between TFRC and other disease factors

    • Apply multilevel models for nested data structures in clinical samples

  • Disease-Specific Considerations:

    • For cancer: Focus on TFRC as both biomarker and therapeutic target

    • For neurodegenerative disorders: Examine iron dysregulation mechanisms

    • For anemia and iron metabolism disorders: Study regulatory pathways

    • For infectious diseases: Investigate pathogen exploitation of TFRC

  • Biomarker Development Pipeline:

    • Discovery phase: Wide screening with appropriate multiple testing correction

    • Validation phase: Independent cohorts with pre-specified endpoints

    • Implementation phase: Standardized assays with defined cutoffs

The development of TransTAC technology, which leverages TFRC's endocytosis mechanism to target membrane proteins for degradation, represents a significant advance in translational applications. This approach has demonstrated promise as a new class of bifunctional antibody for precisely modulating membrane proteins and targeting cancer therapies .

What emerging questions remain unanswered about native TFRC function?

Despite advances in understanding TFRC, several critical questions remain for future research:

  • Regulatory Mechanisms:

    • How do post-translational modifications affect TFRC trafficking and function?

    • What is the role of TFRC in non-canonical iron-independent pathways?

    • How do tissue-specific factors modulate TFRC expression and activity?

  • Structural Dynamics:

    • What conformational changes occur during the TFRC internalization cycle?

    • How do disease-associated mutations affect TFRC structure and function?

    • What is the structural basis for interactions with non-transferrin binding partners?

  • Therapeutic Applications:

    • How can TFRC-targeting strategies be optimized for specific disease contexts?

    • What determines the efficacy of TransTAC approaches in different cell types?

    • How can TFRC-based diagnostics be developed for early disease detection?

Research addressing these questions should implement rigorous experimental designs with appropriate controls, randomization, and statistical power calculations to ensure reproducible and meaningful results .

How should researchers design experiments to resolve contradictory findings in TFRC literature?

Resolving contradictions in the TFRC literature requires specialized experimental approaches:

  • Systematic Review and Meta-analysis:

    • Identify specific contradictions through structured literature review

    • Assess methodological differences that might explain discrepancies

    • Perform formal meta-analysis where sufficient data exists

  • Direct Replication Studies:

    • Design experiments with higher statistical power than original studies

    • Pre-register protocols to prevent publication bias

    • Implement blinding at all possible levels to reduce experimenter bias

  • Factorial Experiments to Test Competing Hypotheses:

    • Design studies that simultaneously test multiple explanatory variables

    • Use 2k factorial or fractional factorial designs for efficiency

    • Implement appropriate statistical models to detect interaction effects

  • Multi-laboratory Validation:

    • Standardize protocols across research sites

    • Implement split-unit designs to evaluate site-specific effects

    • Use hierarchical statistical models to account for site-level variability

When planning such studies, researchers should calculate sample sizes based on the smallest effect size of interest, rather than using previously reported (potentially inflated) effect sizes, to ensure adequate statistical power .

Product Science Overview

Discovery and Structure

The existence of a receptor for transferrin iron uptake has been recognized since the late 1950s . There are two main types of transferrin receptors in humans: transferrin receptor 1 (TfR1) and transferrin receptor 2 (TfR2) . Both of these receptors are transmembrane glycoproteins, but they differ in their expression patterns and affinity for transferrin.

  • TfR1 is a high-affinity receptor that is ubiquitously expressed in various cell types. It is encoded by the TFRC gene and is also known as Cluster of Differentiation 71 (CD71) .
  • TfR2 has a lower affinity for transferrin compared to TfR1 and its expression is restricted to certain cell types .
Function

The primary function of the transferrin receptor is to mediate the uptake of iron into cells. This process occurs through receptor-mediated endocytosis, where the transferrin-iron complex binds to the receptor and is internalized into the cell . Once inside the cell, iron is released from transferrin and utilized for various cellular functions.

Regulation

The production of transferrin receptors is tightly regulated by intracellular iron levels. Low iron concentrations promote increased levels of transferrin receptor to enhance iron intake into the cell . This regulation is mediated by iron-responsive element-binding proteins (IRP1 and IRP2), which bind to the iron-responsive elements (IREs) in the 3’ untranslated region (UTR) of the TfR mRNA . This binding stabilizes the mRNA and prevents its degradation, thereby increasing the production of transferrin receptors.

Clinical Significance

Transferrin receptors have significant clinical implications. They are often overexpressed in rapidly proliferating cells, such as cancer cells, making them potential targets for cancer therapy . Additionally, mutations in the TFRC gene can lead to various disorders related to iron metabolism.

Research and Therapeutic Applications

Recent research has focused on the development of antibody-based therapeutics targeting TfR1 for the treatment of neurological diseases and cancer . For instance, humanized TfR1 knockin mouse models have been developed to assess the efficacy and safety of TfR1-targeted antibody therapies .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.